At times like these, many of us reach for a soothing lozenge to calm the irritation and provide some relief, at least for a ...
Trevi Therapeutics (NASDAQ:TRVI) management used the company’s first-quarter 2026 earnings call to outline upcoming clinical ...
Spring in NYC is famously fickle — we have to prepare for everything from slushy snow and gloomy rain to gusty wind and even ...
Completed follow-on common stock offering with net proceeds of ~$162 million, extending expected cash runway into 2030 ...
Asthma is not always about breathlessness or wheezing. Persistent cough, chest discomfort, fatigue, or exercise intolerance ...
If there’s a cough that’s lasted a couple of days, a stomach ache, a headache that won’t go away… the first thing most of us ...
1hon MSN
Trevi outlines cash runway into 2030 as it plans to start phase III IPF cough trials in Q1 2026
Q1 2026 Management View CEO Jennifer Good said, "2026 is an important year of execution for the company," and tied the quarter’s focus to multiple trial starts across IPF-related chronic cough, ...
Sarasota County Tax Collector Mike Moran was wrong to collect a $2 million fee from the school district. It's time for Moran ...
BBC's Dr Punam Krishan has urged people to stop disregarding potentially serious symptoms, especially following new data ...
Legal in most scenarios, the practice exploits data-driven consumer segmentation and can exacerbate inequality. Common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results